Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
Clinical trial NCT00005987 · TERMINATED
Trial details
- NCT number
- NCT00005987
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2003-07-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.